Darcy Grabenstein

Darcy Grabenstein is Senior Manager of Content Marketing Strategy at TrialScope. With a background in journalism and public relations, she has 30-plus years of experience in communications.

  • Transparency & Other Takeaways from COVID-19 Clinical Trials

    Transparency & Other Takeaways from COVID-19 Clinical Trials

    The COVID-19 pandemic underscores the importance of clinical trial recruitment, data sharing and transparency.

    Read Article
  • An Often-overlooked Way to Participate in Clinical Research

    An Often-overlooked Way to Participate in Clinical Research

    Many blood donors don't realize that their blood also can be used in clinical research. Now, as COVID-19 threatens to create blood shortages, donating blood is more important than ever.

    Read Article
  • What’s Yoga Got to Do with Clinical Trial Access?

    What’s Yoga Got to Do with Clinical Trial Access?

    How setting an intention for yoga can serve as a mantra for anyone working in the healthcare industry.

    Read Article
  • 5 Key KPIs Every Disclosure Team Should Monitor – and Why

    5 Key KPIs Every Disclosure Team Should Monitor – and Why

    Clinical trial disclosure teams must be accountable. Here are five key performance indicators (KPIs) to monitor on a regular basis.

    Read Article
  • TrialScope Acquires Clinical Trial Connect

    TrialScope Acquires Clinical Trial Connect

    Read Article
  • For Sponsors with Global Trials, Online Translation is a Must

    For Sponsors with Global Trials, Online Translation is a Must

    If you conduct global clinical trials and your website is in English only, you are missing out on a huge opportunity to promote your studies. That's why local language translations are crucial.

    Read Article
  • Learn How User Research Boosts Clinical Trial Website ROI

    Learn How User Research Boosts Clinical Trial Website ROI

    Conversion rate optimization and A/B testing are an important part of the online marketing strategy for a clinical trial website.

    Read Article
  • Diversity in Clinical Trials Improving, but We’re Not There Yet

    Diversity in Clinical Trials Improving, but We’re Not There Yet

    Dr. Jean Bonnet, an advocate for diversity in clinical trials, says both sponsors and patients are to blame for the lack of diversity. He says grassroots communication is key to effecting change.

    Read Article
  • With Investors’ Eyes on Biotechs, Biotechs Must Be Transparent

    With Investors’ Eyes on Biotechs, Biotechs Must Be Transparent

    With the government shutdown and public outcry over drug prices, biotech companies face new challenges when courting investors. That means transparency is more important than ever.

    Read Article
  • loading
    Loading More...